State Street Corp Cerus Corp Transaction History

State Street Corp

  • $2.36 Trillion
  • Q1 2025

A detailed history of State Street Corp transactions in Cerus Corp stock. As of the latest transaction made, State Street Corp holds 3,796,476 shares of CERS stock, worth $5.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,796,476
Previous 3,804,616 0.21%
Holding current value
$5.85 Million
Previous $5.86 Million 9.93%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$1.39 - $2.15 $11,314 - $17,501
-8,140 Reduced 0.21%
3,796,476 $5.28 Million
Q4 2024

Feb 14, 2025
BUY
$1.52 - $2.03 $99,898 - $133,417
65,723 Added 1.76%
3,804,616 $5.86 Million
Q3 2024

Nov 14, 2024
BUY
$1.7 - $2.39 $135,158 - $190,016
79,505 Added 2.17%
3,738,893 $6.51 Million
Q2 2024

Aug 14, 2024
SELL
$1.62 - $2.04 $23,583 - $29,698
-14,558 Reduced 0.4%
3,659,388 $6.44 Million
Q1 2024

May 15, 2024
BUY
$1.66 - $2.42 $260,477 - $379,731
156,914 Added 4.46%
3,673,946 $6.94 Million
Q4 2023

Feb 14, 2024
SELL
$1.25 - $2.35 $1.8 Million - $3.39 Million
-1,443,011 Reduced 29.09%
3,517,032 $7.6 Million
Q3 2023

Nov 14, 2023
SELL
$1.5 - $3.07 $274,119 - $561,030
-182,746 Reduced 3.55%
4,960,043 $8.04 Million
Q2 2023

Aug 14, 2023
BUY
$1.79 - $2.9 $595,656 - $965,030
332,769 Added 6.92%
5,142,789 $12.7 Million
Q1 2023

May 15, 2023
BUY
$2.65 - $3.81 $1.67 Million - $2.4 Million
630,719 Added 15.09%
4,810,020 $14.3 Million
Q4 2022

Feb 14, 2023
SELL
$3.38 - $4.22 $2.37 Million - $2.95 Million
-700,229 Reduced 14.35%
4,179,301 $15.3 Million
Q3 2022

Nov 15, 2022
BUY
$3.43 - $5.83 $1.38 Million - $2.35 Million
403,745 Added 9.02%
4,879,530 $17.6 Million
Q2 2022

Aug 15, 2022
SELL
$4.41 - $5.69 $701,009 - $904,476
-158,959 Reduced 3.43%
4,475,785 $23.7 Million
Q1 2022

May 16, 2022
BUY
$4.81 - $6.99 $928,503 - $1.35 Million
193,036 Added 4.35%
4,634,744 $25.4 Million
Q4 2021

Feb 14, 2022
SELL
$5.97 - $7.93 $2.91 Million - $3.86 Million
-486,892 Reduced 9.88%
4,441,708 $30.2 Million
Q3 2021

Nov 15, 2021
BUY
$4.79 - $6.68 $73,641 - $102,698
15,374 Added 0.31%
4,928,600 $30 Million
Q2 2021

Aug 16, 2021
BUY
$5.35 - $6.35 $1.89 Million - $2.25 Million
354,008 Added 7.76%
4,913,226 $29 Million
Q1 2021

May 17, 2021
BUY
$5.68 - $7.87 $1.07 Million - $1.49 Million
188,775 Added 4.32%
4,559,218 $27.4 Million
Q4 2020

Feb 16, 2021
SELL
$5.25 - $8.56 $912,439 - $1.49 Million
-173,798 Reduced 3.82%
4,370,443 $30.2 Million
Q3 2020

Nov 10, 2020
BUY
$5.78 - $7.47 $782,276 - $1.01 Million
135,342 Added 3.07%
4,544,241 $28.4 Million
Q2 2020

Aug 14, 2020
BUY
$4.5 - $7.02 $1.59 Million - $2.47 Million
352,435 Added 8.69%
4,408,899 $29.1 Million
Q1 2020

May 11, 2020
BUY
$2.87 - $5.49 $11.6 Million - $22.3 Million
4,056,464 New
4,056,464 $18.9 Million

Others Institutions Holding CERS

# of Institutions
166
Shares Held
149M
Call Options Held
24.2K
Put Options Held
44.4K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $273M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email